| A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease S Ostrowitzki, RA Lasser, E Dorflinger, P Scheltens, F Barkhof, ... Alzheimer's research & therapy 9, 1-15, 2017 | 469 | 2017 |
| Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs S Retout, S Duffull, F Mentré Computer methods and Programs in Biomedicine 65 (2), 141-151, 2001 | 196 | 2001 |
| Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics S Retout, F Mentré Journal of Biopharmaceutical Statistics 13 (2), 209-227, 2003 | 161 | 2003 |
| Ciprofloxacin dosage and emergence of resistance in human commensal bacteria B Fantin, X Duval, L Massias, L Alavoine, F Chau, S Retout, A Andremont, ... Journal of Infectious Diseases 200 (3), 390-398, 2009 | 154 | 2009 |
| Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients C Clairotte, S Retout, L Potier, R Roussel, B Escoubet Diabetes care 32 (7), 1231-1236, 2009 | 152 | 2009 |
| Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function I Mahé, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ... Thrombosis and haemostasis 97 (04), 581-586, 2007 | 147 | 2007 |
| Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0 C Bazzoli, S Retout, F Mentré Computer methods and programs in biomedicine 98 (1), 55-65, 2010 | 134 | 2010 |
| Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics S Retout, F Mentré, R Bruno Statistics in medicine 21 (18), 2623-2639, 2002 | 121 | 2002 |
| Design in nonlinear mixed effects models: optimization using the Fedorov–Wynn algorithm and power of the Wald test for binary covariates S Retout, E Comets, A Samson, F Mentré Statistics in Medicine 26 (28), 5162-5179, 2007 | 114 | 2007 |
| Optimization of individual and population designs using Splus S Retout, F Mentré Journal of Pharmacokinetics and Pharmacodynamics 30, 417-443, 2003 | 89 | 2003 |
| The use of simulated annealing for finding optimal population designs SB Duffull, S Retout, F Mentré Computer Methods and Programs in Biomedicine 69 (1), 25-35, 2002 | 81 | 2002 |
| Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic … C Bazzoli, S Retout, F Mentré Statistics in medicine 28 (14), 1940-1956, 2009 | 67 | 2009 |
| Risk factors for Enterobacteriaceae bacteremia after liver transplantation C Bellier, F Bert, F Durand, S Retout, J Belghiti, F Mentré, B Fantin Transplant International 21 (8), 755-763, 2008 | 59 | 2008 |
| Modeling Alzheimer's disease progression using disease onset time and disease trajectory concepts applied to CDR‐SOB scores from ADNI I Delor, JE Charoin, R Gieschke, S Retout, P Jacqmin, ... CPT: pharmacometrics & systems pharmacology 2 (10), 1-10, 2013 | 58 | 2013 |
| Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non‐ST‐segment elevation myocardial infarction R Bruno, P Baille, S Retout, N Vivier, C Veyrat‐Follet, GJ Sanderink, ... British journal of clinical pharmacology 56 (4), 407-414, 2003 | 47 | 2003 |
| Comparison of model averaging and model selection in dose finding trials analyzed by nonlinear mixed effect models S Buatois, S Ueckert, N Frey, S Retout, F Mentré The AAPS journal 20, 1-9, 2018 | 43 | 2018 |
| Population pharmacokinetic analysis and exploratory exposure–bleeding rate relationship of emicizumab in adult and pediatric persons with hemophilia A S Retout, C Schmitt, C Petry, F Mercier, N Frey Clinical Pharmacokinetics 59, 1611-1625, 2020 | 37 | 2020 |
| Item response theory as an efficient tool to describe a heterogeneous clinical rating scale in de novo idiopathic Parkinson’s disease patients S Buatois, S Retout, N Frey, S Ueckert Pharmaceutical research 34 (10), 2109-2118, 2017 | 37 | 2017 |
| Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics FP Combes, S Retout, N Frey, F Mentré Pharmaceutical research 30, 2355-2367, 2013 | 36 | 2013 |
| Predicted propofol effect-site concentration for induction and emergence of anesthesia during early pregnancy N Mongardon, F Servin, M Perrin, E Bedairia, S Retout, C Yazbeck, ... Anesthesia & Analgesia 109 (1), 90-95, 2009 | 36 | 2009 |
